Citations 3
Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis
Blair, Janis E. , Wang, Sharon, Bercovitch, Robert, Bolaris, Michael , Akker, Dane Van Den, Heidari, Arash , Catanzaro, Antonino , Chin‐Hong, Peter , Spellberg, Brad , Johnson, Royce H. , Thompson, George R , López, Rodrigo , Cadena, José
Clinical Infectious Diseases | April 10, 2017 | Volume: 65 | Issue: 2 | Pages: 338-341
1459Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis
Wang, Sharon, Bercovitch, Robert, Bolaris, Michael , Akker, Dane Van Den, Catanzaro, Antonio, Zuluaga, Jose Cadena, Chin‐Hong, Peter , Spellberg, Brad , Blair, Janis E. , Johnson, Royce H. , Thompson, George R , López, Rodrigo , Heidari, Arash
Open Forum Infectious Diseases | February 1, 2017 | Volume: 1 | Issue: suppl_1 | Pages: S384-S385
Voriconazole Use for Endemic Fungal Infections
Freifeld, Alison G. , Proia, Laurie A., Andes, David R. , Blair, Janis E. , Spellberg, Brad , Arnold, Sandra R. , Lentnek, Arnold, Wheat, L. Joseph , Baddour, Larry M.
Antimicrobial Agents and Chemotherapy | January 12, 2009 | Volume: 53 | Issue: 4 | Pages: 1648-1651
ABSTRACT In a retrospective review of 24 patients with histoplasmosis, blastomycosis, or coccidioidomycosis treated with voriconazole (most for salvage therapy), the outcome was favorable (improved or stable) for 22 (95.8%) within 2 months of starting voriconazole and for 20 (83.3%) at the last follow-up. Prospective studies are required to determine its role in the treatment of endemic mycoses.